SCHEMBL5155976

SCHEMBL5155976

C1=CCOC=CN=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11237979 0.86
SCHEMBL11237977 0.86
SCHEMBL4707971 0.80
SCHEMBL4707967 0.80
Hydrochloric Acid SCHEMBL31513934 0.78
SCHEMBL31570729 0.76
SCHEMBL31570726 0.76
SCHEMBL12505723 0.74
SCHEMBL29069129 0.74
SCHEMBL10430740 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740558-A1 BENZOXAZOCINES AND THEIR THERAPEUTIC USE AS MONOAMINE REUPTAKE INHIBITORS Sosei R&D Ltd. (GB) 2007-01-10 EP claimed
WO-2005103019-A1 BENZOXAZOCINES AND THEIR THERAPEUTIC USE AS MONOAMINE REUPTAKE INHIBITORS SOSEI R&D LTD. (GB) 2005-11-03 WO claimed